CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perez, C.
Right arrow Articles by Aller, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perez, C.
Right arrow Articles by Aller, P.

Cell Growth & Differentiation, Vol 5, Issue 9 949-955, Copyright © 1994 by American Association of Cancer Research


ARTICLES

Etoposide-induced differentiation of U937 promonocytic cells: AP-1-dependent gene expression and protein kinase C activation

C Perez, NE Vilaboa and P Aller
Instituto de Quimica Medica, Consejo Superior de Investigaciones Cientificas, Madrid, Spain.

The administration of 150 nM etoposide, an inhibitor of DNA topoisomerase II activity, decreased the proliferation and induced the differentiation of U937 human promonocytic cells, as determined by nitroblue tetrazolium reduction, surface accumulation of CD11b/CD18 and CD11c/CD18 integrins, and c-fms protooncogene expression. The expression of these differentiation markers started to be detected at 24 h of treatment. Etoposide caused little cell damage, as determined by trypan blue exclusion and by apoptotic-like DNA degradation, which was slightly initiated at 48 h. The treatment induced a transient increase in c-fos, c-jun, and jun B mRNA levels, with maximum values at 12 h, a transient increase in collagenase mRNA level, with maximum value at 48 h, and a progressive increase in vimentin and lamin A and C mRNAs. These changes were qualitatively similar to those produced by 12-O-tetradecanoylphorbol-13-acetate. Etoposide also caused a transient increase of total AP-1 binding activity, with maximum value at 12 h of treatment, as determined by gel retardation assays. The drug produced an early transient activation (3-6 h) of membrane-bound protein kinase C, followed by the later activation (48 h) of both the membrane and cytosolic enzyme. The protein kinase C inhibitors, sphinganine and 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H7), attenuated the induction of differentiation markers by etoposide. These results suggest that protein kinase C and AP-1-dependent gene expression could be involved in myeloid cell differentiation by DNA topoisomerase II inhibitors.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
W. D. Jarvis, C. R. Johnson, F. A. Fornari, J. S. Park, P. Dent, and S. Grant
Evidence That the Apoptotic Actions of Etoposide Are Independent of c-Jun/Activating Protein-1-Mediated Transregulation
J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1384 - 1392.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
L. Garcia-Bermejo, C. Perez, N. E. Vilaboa, E. de Blas, and P. Aller
cAMP increasing agents attenuate the generation of apoptosis by etoposide in promonocytic leukemia cells
J. Cell Sci., March 1, 1998; 111(5): 637 - 644.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
N. E. Vilaboa, L. Garcia-Bermejo, C. Perez, E. de Blas, C. Calle, and P. Aller
Heat-shock and cadmium chloride increase the vimentin mRNA and protein levels in U-937 human promonocytic cells
J. Cell Sci., January 1, 1997; 110(2): 201 - 207.
[Abstract] [PDF]


Home page
J Biol ChemHome page
J. Aragones, C. Lopez-Rodriguez, A. Corbi, P. G. del Arco, M. Lopez-Cabrera, M. O. de Landazuri, and J. M. Redondo
Dithiocarbamates Trigger Differentiation and Induction of CD11c Gene through AP-1 in the Myeloid Lineage
J. Biol. Chem., May 3, 1996; 271(18): 10924 - 10931.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1994 by the American Association of Cancer Research.